{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:41:58Z","timestamp":1792532518925,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00213-024-06721-7","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T23:44:58Z","timestamp":1732319098000},"page":"855-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of the nicotine uptake and safety of Nordic spirit tobacco-free oral nicotine pouches: A randomized cross-over study"],"prefix":"10.1007","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9400-6189","authenticated-orcid":false,"given":"Karine","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Larroque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"6721_CR1","doi-asserted-by":"publisher","unstructured":"Aldeek F, Mccutcheon N, Smith C, et al (2021) Dissolution Testing of Nicotine Release from OTDN Pouches: Product Characterization and Product-to-Product Comparison. https:\/\/doi.org\/10.3390\/separations80","DOI":"10.3390\/separations80"},{"key":"6721_CR2","doi-asserted-by":"publisher","unstructured":"Azzopardi D, Ebajemito J, McEwan M, et al (2022a) A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products. Sci Rep 12. https:\/\/doi.org\/10.1038\/s41598-022-10544-x","DOI":"10.1038\/s41598-022-10544-x"},{"key":"6721_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/1354750X.2022.2148747","volume":"28","author":"D Azzopardi","year":"2023","unstructured":"Azzopardi D, Haswell LE, Frosina J et al (2023) Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers. Biomarkers 28:118\u2013129. https:\/\/doi.org\/10.1080\/1354750X.2022.2148747","journal-title":"Biomarkers"},{"key":"6721_CR4","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1080\/01480545.2021.1925691","volume":"45","author":"D Azzopardi","year":"2022","unstructured":"Azzopardi D, Liu C, Murphy J (2022b) Chemical characterization of tobacco-free \u201cmodern\u201d oral nicotine pouches and their position on the toxicant and risk continuums. Drug Chem Toxicol 45:2246\u20132254. https:\/\/doi.org\/10.1080\/01480545.2021.1925691","journal-title":"Drug Chem Toxicol"},{"key":"6721_CR5","doi-asserted-by":"publisher","unstructured":"Back S, Masser AE, Rutqvist LE, Lindholm J (2023) Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs). BMC Chem 17. https:\/\/doi.org\/10.1186\/s13065-023-00918-1","DOI":"10.1186\/s13065-023-00918-1"},{"key":"6721_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.drugalcdep.2007.04.002","volume":"90","author":"JC Cappelleri","year":"2007","unstructured":"Cappelleri JC, Bushmakin AG, Baker CL et al (2007) Multivariate framework of the Brief Questionnaire of Smoking Urges. Drug Alcohol Depend 90:234\u2013242. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.04.002","journal-title":"Drug Alcohol Depend"},{"key":"6721_CR7","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s00213-022-06178-6","volume":"239","author":"F Chapman","year":"2022","unstructured":"Chapman F, McDermott S, Rudd K et al (2022) A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes. Psychopharmacology 239:2931\u20132943. https:\/\/doi.org\/10.1007\/s00213-022-06178-6","journal-title":"Psychopharmacology"},{"key":"6721_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/s41591-022-01978-x","volume":"28","author":"X Dai","year":"2022","unstructured":"Dai X, Gil GF, Reitsma MB et al (2022) Health effects associated with smoking: a Burden of Proof study. Nat Med 28:2045\u20132055. https:\/\/doi.org\/10.1038\/s41591-022-01978-x","journal-title":"Nat Med"},{"key":"6721_CR9","unstructured":"European Medicines Agency (1995) ICH Topic E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting"},{"key":"6721_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMp1707409","volume":"377","author":"S Gottlieb","year":"2017","unstructured":"Gottlieb S, Zeller M (2017) A Nicotine-Focused Framework for Public Health. N Engl J Med 377:1111\u20131114. https:\/\/doi.org\/10.1056\/NEJMp1707409","journal-title":"N Engl J Med"},{"key":"6721_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/ntr\/nts265","volume":"15","author":"DK Hatsukami","year":"2013","unstructured":"Hatsukami DK, Zhang Y, O\u2019Connor RJ, Severson HH (2013) Subjective responses to oral tobacco products: Scale validation. Nicotine Tob Res 15:1259\u20131264. https:\/\/doi.org\/10.1093\/ntr\/nts265","journal-title":"Nicotine Tob Res"},{"key":"6721_CR12","volume-title":"Clearing the smoke : assessing the science base for tobacco harm reduction","author":"Institute of Medicine","year":"2001","unstructured":"Institute of Medicine (2001) Clearing the smoke\u202f: assessing the science base for tobacco harm reduction. National Academy Press, Washington, D.C."},{"key":"6721_CR13","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s00213-022-06172-y","volume":"239","author":"J Liu","year":"2022","unstructured":"Liu J, Rensch J, Wang J et al (2022) Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users. Psychopharmacology 239:2863\u20132873. https:\/\/doi.org\/10.1007\/s00213-022-06172-y","journal-title":"Psychopharmacology"},{"key":"6721_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ntr\/ntr044","volume":"13","author":"E Lunell","year":"2011","unstructured":"Lunell E, Curvall M (2011) Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine Tob Res 13:573\u2013578. https:\/\/doi.org\/10.1093\/ntr\/ntr044","journal-title":"Nicotine Tob Res"},{"key":"6721_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/ntr\/ntaa068","volume":"22","author":"E Lunell","year":"2020","unstructured":"Lunell E, Fagerstr\u00f6m K, Hughes J, Pendrill R (2020) Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff. Nicotine Tob Res 22:1757\u20131763. https:\/\/doi.org\/10.1093\/ntr\/ntaa068","journal-title":"Nicotine Tob Res"},{"key":"6721_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s13318-021-00742-9","volume":"47","author":"M McEwan","year":"2022","unstructured":"McEwan M, Azzopardi D, Gale N et al (2022) A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette. Eur J Drug Metab Pharmacokinet 47:211\u2013221. https:\/\/doi.org\/10.1007\/s13318-021-00742-9","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"6721_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.toxrep.2022.06.008","volume":"9","author":"J Miller-Holt","year":"2022","unstructured":"Miller-Holt J, Baskerville-Abraham I, Sakimura M et al (2022) In vitro evaluation of mutagenic, cytotoxic, genotoxic and oral irritation potential of nicotine pouch products. Toxicol Rep 9:1316\u20131324. https:\/\/doi.org\/10.1016\/j.toxrep.2022.06.008","journal-title":"Toxicol Rep"},{"key":"6721_CR18","doi-asserted-by":"publisher","first-page":"1000184","DOI":"10.4172\/2155-6105.1000184","volume":"5","author":"WB Pickworth","year":"2014","unstructured":"Pickworth WB, Rosenberry ZR, Gold W, Koszowski B (2014) Nicotine Absorption from Smokeless Tobacco Modified to Adjust pH. J Addict Res Ther 5:1000184. https:\/\/doi.org\/10.4172\/2155-6105.1000184","journal-title":"J Addict Res Ther"},{"key":"6721_CR19","doi-asserted-by":"publisher","unstructured":"Price LR, Martinez J (2019) Biological effects of nicotine exposure: A narrative review of the scientific literature. F1000Res 8:1586. https:\/\/doi.org\/10.12688\/f1000research.20062.1","DOI":"10.12688\/f1000research.20062.1"},{"key":"6721_CR20","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/jcph.2293","volume":"63","author":"J Rensch","year":"2023","unstructured":"Rensch J, Edmiston J, Wang J et al (2023) A Randomized, Controlled Study to Assess Changes in Biomarkers of Exposures Among Adults Who Smoke That Switch to Oral Nicotine Pouch Products Relative to Continuing Smoking or Stopping All Tobacco Use. J Clin Pharmacol 63:1108\u20131118. https:\/\/doi.org\/10.1002\/jcph.2293","journal-title":"J Clin Pharmacol"},{"key":"6721_CR21","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1007\/s00213-021-05948-y","volume":"238","author":"J Rensch","year":"2021","unstructured":"Rensch J, Liu J, Wang J et al (2021) Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!\u00ae nicotine pouches compared to combustible cigarettes. Psychopharmacology 238:3325\u20133334. https:\/\/doi.org\/10.1007\/s00213-021-05948-y","journal-title":"Psychopharmacology"},{"key":"6721_CR22","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/ntr\/ntab030","volume":"23","author":"S Stanfill","year":"2021","unstructured":"Stanfill S, Tran H, Tyx R et al (2021) Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products. Nicotine Tob Res 23:1590\u20131596. https:\/\/doi.org\/10.1093\/ntr\/ntab030","journal-title":"Nicotine Tob Res"},{"key":"6721_CR23","unstructured":"United States Department of Health and Human Services (2014) The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA."},{"key":"6721_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/aivt.2021.0020","volume":"8","author":"F Yu","year":"2022","unstructured":"Yu F, Rudd K, Pour SJ et al (2022) Preclinical Assessment of Tobacco-Free Nicotine Pouches Demonstrates Reduced in Vitro Toxicity Compared with Tobacco Snus and Combustible Cigarette Smoke. Appl in Vitro Toxicol 8:24\u201335. https:\/\/doi.org\/10.1089\/aivt.2021.0020","journal-title":"Appl in Vitro Toxicol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06721-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:11:38Z","timestamp":1741601498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06721-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6721"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06721-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted by CTC Clinical Trial Consultants AB under contract to JTI in accordance with ethical principles that have their origin in the Declaration of Helsinki, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6 (R2) guideline for Good Clinical Practice (GCP), as well as the European Union (EU) Clinical Trials Directive 2001\/20\/EC. The participants\u2019 personal data was protected in accordance with the EU General Data Protection Regulation (GDPR) 2016\/679. The study was approved by a competent authority (Swedish Medical Products agency approval no. 5.1\u20132020-60886) and an independent ethics committee (Swedish Ethical Review Authority approval no. 2020\u201305745) prior to study initiation. All participants in the study reviewed, signed, and dated an informed consent form prior to study initiation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the study, D.N. was employed by Japan Tobacco Inc., and K.R., S.L., L.G. and J.M. were employed by JT International SA. J.N. was employed by CTC Clinical Trial Consultants AB and was the Principal Investigator of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}